Patent application number | Description | Published |
20090199567 | DECOUPLER DEVICES TO PREVENT BACKDRIVE IN AIR TURBINE STARTERS - An air turbine starter for starting an engine includes a housing, and a flow path communicating a flow of gas therethrough; a turbine member; a clutch; and a decoupler device at least partially housed within the output member of the clutch. The decoupler device includes a first shaft portion coupled to and rotating with the output member and a second shaft portion coupled to and rotating with the engine. The first and second shaft portions are axially aligned and configured to engage each another for rotation in a first direction and to separate from each other in a second direction to decouple the output member of the clutch from the engine. The starter further includes a bearing between the inner surface of the output member and the second shaft portion for reducing friction between the second shaft portion and the inner surface of the output member when the first and second shaft portions are decoupled. | 08-13-2009 |
20090266948 | HUMAN-MACHINE INTERFACE TWO AXIS GIMBAL MECHANISM - A relatively simple, relatively small, relatively light-weight, and relatively inexpensive two-axis gimbal mechanism for a human-machine interface is provided. The gimbal assembly includes a first bracket, a second bracket, a center body, a first centering mechanism, and a second centering mechanism. The first bracket and second brackets each includes a first arm, a second arm, and a third arm. The first and second arms form substantially L-shaped sections and the third arms substantially perpendicular from the first arms. The center body is disposed between the L-shaped sections, and is rotatable from a null position about first and second rotational axes. The first and second centering mechanisms are coupled to the third arms of the first and second brackets, respectively, and are configured to supply a first centering force that urges the center body toward a null position when the center body is rotated about the rotational axes. | 10-29-2009 |
20100270489 | BUTTERFLY VALVE ASSEMBLY INCLUDING A BEARING ASSEMBLY FOR SERRATED SPLINE CONSTRAINT - Butterfly valves assemblies are provided that include a flowbody, a butterfly plate, an actuator and an upper chimney and a lower chimney disposed within the flowbody. The flowbody has an inner surface defining a channel. The butterfly plate is disposed in the channel, is rotationally mounted to the flowbody, and has an outer periphery. The actuator has an actuator output shaft that is coupled to the valve shaft via a serrated spline coupling. The upper chimney and the lower chimney are configured to include bearing assemblies that constrain radial loads and thrust loads exerted upon the valve shaft and minimize misalignment of the serrated spline coupling. | 10-28-2010 |
20110084226 | FULL STRAIGHT-SHAFT SEALING BUTTERFLY VALVE - A straight shaft sealing valve assembly includes a valve body, a shaft, a valve element, and a seal element. The valve body has an inner surface that defines a flow channel. The shaft is rotationally mounted on the valve body and extends across the flow channel. The shaft includes a first seal opening and a second seal opening. The first and second seal openings are spaced apart from each other and extend through the shaft. The valve element is coupled to the shaft and is rotatable therewith, and has an outer periphery. The seal element is coupled to the valve element, extends from the outer periphery, and extends through the first and second seal openings. | 04-14-2011 |
Patent application number | Description | Published |
20110076294 | Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing - The present invention provides a fluid exchange cell culture technique and tissue repair cells (TRCs) made by these methods, as well as methods using these cells. The method includes a new wash step which increases the tissue repair properties of the TRCs of the invention. This wash step allows for the production of TRC populations with greater tissue repair and anti-inflammatory capabilities. Embodiments of the present invention include a post-culture process for cultured cells that preferably includes the steps of: a wash process for removing unwanted residual culture components, a volume reduction process, and a harvesting process to remove cultured cells. Preferably, all these steps are performed within a aseptically closed cell culture chamber by implementing a separation method that minimizes mechanical disruption of the cells and is simple to automate. The harvested cells may then be concentrated to a final volume for the intended use. In such embodiments, the final composition is a substantially purified and concentrated cell mixture suspended in a physiologic solution suitable for immediate use in humans without further washing, volume reduction, or processing. Embodiments are also applicable to harvesting (and/or washing) particles within a liquid or solution within a chamber. | 03-31-2011 |
20110124105 | Mixed Cell Populations For Tissue Repair And Separation Technique For Cell Processing - The present invention provides a fluid exchange cell culture technique and tissue repair cells (TRCs) made by these methods, as well as methods using these cells. The method includes a new wash step which increases the tissue repair properties of the TRCs of the invention. This wash step allows for the production of TRC populations with greater tissue repair and anti-inflammatory capabilities. Embodiments of the present invention include a post-culture process for cultured cells that preferably includes the steps of: a wash process for removing unwanted residual culture components, a volume reduction process, and a harvesting process to remove cultured cells. Preferably, all these steps are performed within a aseptically closed cell culture chamber by implementing a separation method that minimizes mechanical disruption of the cells and is simple to automate. The harvested cells may then be concentrated to a final volume for the intended use. In such embodiments, the final composition is a substantially purified and concentrated cell mixture suspended in a physiologic solution suitable for immediate use in humans without further washing, volume reduction, or processing. Embodiments are also applicable to harvesting (and/or washing) particles within a liquid or solution within a chamber. | 05-26-2011 |
Patent application number | Description | Published |
20100125450 | SYNCHRONIZED TRANSCRIPTION RULES HANDLING - Methods, systems, and software are disclosed for providing rule handling functionality in a distributed transcription environment. Some embodiments provide client-server workflow management for providing and supporting distributed transcription services. Other embodiments provide audio-to-text synchronization to support certain transcription functionality. Still other embodiments provide logging functionality to support quality, personnel, billing, and/or other enterprise tasks. And other embodiments provide functionality to support rule generation, editing, validation, and/or execution. | 05-20-2010 |
20140303977 | Synchronized Transcription Rules Handling - Methods, systems, and software are disclosed for providing rule handling functionality in a distributed transcription environment. Some embodiments provide client-server workflow management for providing and supporting distributed transcription services. Other embodiments provide audio-to-text synchronization to support certain transcription functionality. Still other embodiments provide logging functionality to support quality, personnel, billing, and/or other enterprise tasks. And other embodiments provide functionality to support rule generation, editing, validation, and/or execution. | 10-09-2014 |
Patent application number | Description | Published |
20090132030 | Method Of Modifying A Metal Substrate To Improve Surface Coverage Of A Coating - This application relates to a method of modifying the surface of a metal substrate to improve the surface coverage of a coating applied to the substrate. The method comprises heating at least the surface of the substrate to a temperature within the range of approximately 175-400° C.; and applying at least one layer of the coating to the substrate. In one particular embodiment the substrate is heated to a temperature within the range of 200-350° C. The low temperature heating enhances the hydrophilicity of the metal substrate while avoiding the disadvantages of high temperature thermal oxidation. | 05-21-2009 |
20090197975 | COMPOSITIONS FORMULATED FOR SOLVENT-REGULATED DRUG RELEASE - This application relates to a composition comprising a mixture of different organic solvents formulated for controlled drug release. The release profile of the drug can be regulated by adjusting the compositional ratios of the solvents. In one embodiment of the invention a first solvent is water-soluble and a second solvent is water-insoluble. The first and second solvents are miscible and together form a solution containing the drug. The hydrophobicity of the composition can be adjusted by altering the relative amount of the second solvent. The composition also includes a solid lipid dissolved in the drug-containing solution. In aqueous environments the lipid may precipitate to form a thin membrane in an outer surface portion of the composition, thereby further regulating the release of the drug. The membrane is preferably renewable. That is, as the outermost portion of the lipid is biodegraded at a target location in vivo, additional outer portions of the lipid precipitate to renew the thin membrane. The composition may be formulated, for example, as a suspension, nanoparticle, microparticle, paste or thin film coating. In one particular embodiment, the composition may be applied to an implantable medical device, such as a cardiovascular stent. | 08-06-2009 |
20100018865 | ELECTROLYTE SOLUTION AND METHOD FOR ELECTROLYTIC CO-DEPOSITION OF THIN FILM CALCIUM PHOSPHATE AND DRUG COMPOSITES - Disclosed herein are electrolyte solutions and methods for electrolytic co-deposition of calcium phosphate and drug composites. The electrolyte solution may be formed by mixing solutions comprising calcium and phosphate precursors together to form an electrolyte solution. The electrolyte solution can have a water content less than 30 weight percent. The electrolyte solution may comprise a water-soluble non-aqueous solvent. A therapeutic agent, such as water-insoluble drug, is also present in the solution. The electrolyte solution thus formed may be used to co-deposit a calcium phosphate coating and the therapeutic agent on a substrate. One method includes the steps of immersing the substrate in the electrolyte solution and applying an electrical potential to the substrate to thereby cause (i) the calcium and phosphate precursors to electrochemically react with hydroxyl groups on the surface of the substrate and deposit the calcium phosphate coating thereon; and (ii) the therapeutic agent to electrophoretically migrate to the substrate and become co-deposited thereon together with the calcium phosphate coating. The method thus provides a convenient and easily controllable means for depositing thin film calcium phosphate and drug composites on substrates such as implantable medical devices. | 01-28-2010 |
Patent application number | Description | Published |
20110145704 | PROVIDING MULTIPLE VIEWS OF A BUSINESS PROCESS DEFINITION TO DIFFERENT VIEWS - In one embodiment, a method for providing multiple views of a business process definition includes storing a model of a business process, and providing different view points of the model to different classes of users. | 06-16-2011 |
20110202473 | Progressive Refinement Model for Business Processes - In one embodiment, a method for refining a business process model includes receiving business process data pertaining to a first phase of a business process definition from a first class of users, creating a model of a business process using the business process data received from the first class of users, receiving business process data pertaining to a second phase of the business process definition from a second class of users, and augmenting the model of the business process based on the business process data received from the second class of users. The method further includes iteratively refining the model of the business process in response to input provided by the first class of users and/or the second class of users. | 08-18-2011 |
20120005116 | MODELING OF BUSINESS PROCESS DATA - In one embodiment, a business process meta-model is defined that represents a business process. The business process meta-model includes control flow elements pertaining to a control flow of the business process, and annotation elements providing details for the control flow elements. | 01-05-2012 |
20130238386 | MODELING OF BUSINESS PROCESS DATA - In one embodiment, a business process meta-model is defined that represents a business process. The business process meta-model includes control flow elements pertaining to a control flow of the business process, and annotation elements providing details for the control flow elements. | 09-12-2013 |
20140310055 | Progressive Refinement Model for Business Processes - In one embodiment, a method for refining a business process model includes receiving business process data pertaining to a first phase of a business process definition from a first class of users, creating a model of a business process using the business process data received from the first class of users, receiving business process data pertaining to a second phase of the business process definition from a second class of users, and augmenting the model of the business process based on the business process data received from the second class of users. The method further includes iteratively refining the model of the business process in response to input provided by the first class of users and/or the second class of users. | 10-16-2014 |